The Top Analysis for Gilead Sciences, Inc. (GILD)

The top analysis was written by Noah Brody titled Which is the Better Buy? Gilead Sciences vs Bristol-Myers Squibb

Is Gilead Sciences, Inc. (GILD) a buy?

Based on 1 suggestion, Gilead Sciences, Inc.(GILD) is recommended as a HOLD at $66.98.

Are These Ratings Good?

Based on 1 ratings, the average Return is 0.99%.
The community has successfully rated this stock!

Forecast for Gilead Sciences, Inc. (GILD)

Based on the most recent price of $67.65,
the two year forecast for GILD is $71.03.
The four year forecast is $74.42
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.